Company Profile | ![]() | 0-9 | ![]() | A | ![]() | B | ![]() | C | ![]() | D | ![]() | E | ![]() | F | ![]() | G | ![]() | H | ![]() | I | ![]() | J | ![]() | K | ![]() | L | ![]() | M | ![]() | N | ![]() | O | ![]() | P | ![]() | Q | ![]() | R | ![]() | S | ![]() | T | ![]() | U | ![]() | V | ![]() | W | ![]() | X | ![]() | Y | ![]() | Z |
BioLineRX
(NASDAQ: BLRX)
|
8:00 PM UTC, 04/17/25 | |||
---|---|---|---|---|
Last: $2.88 | Change: +0.13 | %Change: +4.88% | Volume: 8,953 |
01/17/2025 1:30pm | BioLineRx Changes Ratio of ADSs to Ordinary Shares |
01/17/2025 1:30pm | BioLineRx Changes Ratio of ADSs to Ordinary Shares |
09/04/2024 7:47am | --JonesTrading Initiates BioLineRx at Buy With $2 Price Target |